Company: JUNS
Filing Date: 2025-11-26
Form Type: S-1
Source: 0001493152-25-025204
Chunk: 167

Company: JUPITER NEUROSCIENCES, INC.
Filing Date: 2025-11-26
Form: S-1
Chunk 167
---
 1001 North US Hwy 1, Suite 504, Jupiter, Florida 33477, where we lease approximately 1,206 rentable square feet of office
space. This lease expires on May 31, 2026. Terms of the office lease provide for a base rent payment of $3,783 per month and a share of
the building’s operating expenses, such as taxes and maintenance, of $476 per month. In September 2021, we added an additional office
located at 127 Main Street, Boston, Massachusetts 02129 for 120 rentable square feet of office space for our Boston-based employees and
scientist to utilize as necessary.

We believe that these facilities
are adequate for our current and near-term future needs.

Employees

As of November 25,
2025, we had a total of four full-time employees, two full-time consultants, one part-time consultant, and our six Scientific Advisory
Board members. Of these, three were primarily engaged in research or product development and clinical activities.

| 96 |

<div align='center'>MANAGEMENT</div>

The following table sets
forth the names and ages of the members of our Board of Directors and our executive officers and the positions held by each as of November
25, 2025. Our Board of Directors elects our executive officers annually by majority vote. Each director’s term continues
until his or her successor is elected or qualified at the next annual meeting, unless such director earlier resigns or is removed. In
addition, the following table sets forth the names and ages of the members of our Science Advisory Board.

| Name                             |     | Age |     | Positions Held                                          |
| Executive Officers and Directors |     |     |     |                                                         |
| Christer Rosén                   |     |  73 |     | Chairman of Board, Chief Executive Officer and Director |
| Saleem Elmasri, CPA              |     |  39 |     | Chief Financial Officer and Secretary                   |
| Marshall Hayward, Ph.D.          |     |  70 |     | Chief Scientific Officer and Director                   |
| Alexander Rosén                  |     |  34 |     | Chief Administrative Officer                            |
| Alison D. Silva                  |     |  46 |     | President, Chief Business Officer, and Director         |
| Nicholas H. Hemmerly             |     |  42 |     | Independent Director                                    |
| Julie Kampf                      |     |  63 |